An obesity genetic risk score is associated with metabolic syndrome in Chinese children.
Genetic Rodent Models of Obesity-Associated Ovarian Dysfunction and Subfertility: Insights into Polycystic Ovary Syndrome.
Obesity-associated genetic variants in young Asian Indians with the metabolic syndrome and myocardial infarction.
Current Treatments for Patients with Genetic Obesity.
Faccioli N, Poitou C, Clément K, Dubern B.
J Clin Res Pediatr Endocrinol. 2023 May 29;15(2):108-119. doi: 10.4274/jcrpe.galenos.2023.2023-3-2. Epub 2023 May 16.
Obesity and female infertility: potential mediators of obesity's impact.
Broughton DE, Moley KH.
Fertil Steril. 2017 Apr;107(4):840-847. doi: 10.1016/j.fertnstert.2017.01.017. Epub 2017 Mar 11.
Hypothalamic syndrome.
Müller HL, Tauber M, Lawson EA, Özyurt J, Bison B, Martinez-Barbera JP, Puget S, Merchant TE, van Santen HM.
Nat Rev Dis Primers. 2022 Apr 21;8(1):24. doi: 10.1038/s41572-022-00351-z.
Prader-Willi syndrome.
Cassidy SB, Schwartz S, Miller JL, Driscoll DJ.
Genet Med. 2012 Jan;14(1):10-26. doi: 10.1038/gim.0b013e31822bead0. Epub 2011 Sep 26.
The role of diet in hyperuricemia and gout.
Yokose C, McCormick N, Choi HK.
Curr Opin Rheumatol. 2021 Mar 1;33(2):135-144. doi: 10.1097/BOR.0000000000000779.
Microbial Medicine: Prebiotic and Probiotic Functional Foods to Target Obesity and Metabolic Syndrome.
Green M, Arora K, Prakash S.
Int J Mol Sci. 2020 Apr 21;21(8):2890. doi: 10.3390/ijms21082890.
Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alstrom syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period.
Haqq AM, Chung WK, Dollfus H, Haws RM, Martos-Moreno GÁ, Poitou C, Yanovski JA, Mittleman RS, Yuan G, Forsythe E, Clément K, Argente J.
Lancet Diabetes Endocrinol. 2022 Dec;10(12):859-868. doi: 10.1016/S2213-8587(22)00277-7. Epub 2022 Nov 7.
Special Issue: Genetics of Prader-Willi Syndrome.
Godler DE, Butler MG.
Genes (Basel). 2021 Sep 16;12(9):1429. doi: 10.3390/genes12091429.
Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings.
Angulo MA, Butler MG, Cataletto ME.
J Endocrinol Invest. 2015 Dec;38(12):1249-63. doi: 10.1007/s40618-015-0312-9. Epub 2015 Jun 11.
Effect of semaglutide on weight loss and glycaemic control in patients with Prader-Willi Syndrome and type 2 diabetes.
Giménez-Palop O, Romero A, Casamitjana L, Pareja R, Rigla M, Caixàs A.
Endocrinol Diabetes Nutr (Engl Ed). 2024 Feb;71(2):83-87. doi: 10.1016/j.endien.2023.12.001.
